Jul 26, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
It’s no lie the drug development model is in need of a drastic shakeup. With lengthy and costly approval processes, generic incursion, rising development costs and the need for novel adherence strategies, pharma and biotech, now more than ever need to initiate...
